Research
Metabolic adaptation
Metabolic and bariatric surgery (MBS) achieves superior comorbidity remission compared to intensive medical therapy.
MBS should be considered as a primary treatment option for patients with severe obesity and related comorbidities.
StrongSupportsmedium confidence
Long-term data (e.g. SLEEVEPASS and STAMPEDE) confirm MBS achieves superior comorbidity remission compared to intensive medical therapy.
Why this rating
Based on long-term data from studies like SLEEVEPASS and STAMPEDE.
Source
The evolving landscape of metabolic surgery: An evidence-based review
Vidit Dholakia et al. · Journal of Minimal Access Surgery · 2026
DOI 10.4103/jmas.jmas_551_25
Meta-analysis
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Laparoscopic Roux-en-Y gastric bypass provides superior long-term remission of dyslipidaemia, hypertension, and gastro-oesophageal reflux disease compared to laparoscopic sleeve gastrectomy.Strong
- Emerging single-anastomosis variants demonstrate promising efficacy and improved gastrointestinal profiles.Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →